After surgery, breast cancer-related lymphedema (BCRL) is a frequent chronic condition. The complex decongestive therapy (CDT) delivered by physiotherapists at hospitals is the state-of-the-art treatment choice. As lymphedema requires continuous management, we designed a 1-month-long course to train women to professionally carry out a self-administered CDT (saCDT) and tested its efficacy while keeping the benefits of CDT.
Efficacy of self-administered complex decongestive therapy on breast cancer-related lymphedema: a single-blind randomized controlled trial / Ligabue, M B; Campanini, I; Veroni, PIER PAOLO; Cepelli, A; Lusuardi, M; Merlo, A. - In: BREAST CANCER RESEARCH AND TREATMENT. - ISSN 0167-6806. - 175:1(2019), pp. 191-201. [10.1007/s10549-019-05136-9]
Efficacy of self-administered complex decongestive therapy on breast cancer-related lymphedema: a single-blind randomized controlled trial
VERONI, PIER PAOLO;Lusuardi, M;Merlo, A
2019
Abstract
After surgery, breast cancer-related lymphedema (BCRL) is a frequent chronic condition. The complex decongestive therapy (CDT) delivered by physiotherapists at hospitals is the state-of-the-art treatment choice. As lymphedema requires continuous management, we designed a 1-month-long course to train women to professionally carry out a self-administered CDT (saCDT) and tested its efficacy while keeping the benefits of CDT.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Ligabue2019_Article_EfficacyOfSelf-administeredCom.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
1.8 MB
Formato
Adobe PDF
|
1.8 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
